Allianz Asset Management GmbH Acquires 297,577 Shares of GE HealthCare Technologies Inc. $GEHC

Allianz Asset Management GmbH boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 752.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 337,115 shares of the company’s stock after acquiring an additional 297,577 shares during the period. Allianz Asset Management GmbH’s holdings in GE HealthCare Technologies were worth $25,317,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. E Fund Management Hong Kong Co. Ltd. grew its stake in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares during the last quarter. Allianz SE increased its position in GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares in the last quarter. Oakworth Capital Inc. increased its position in GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares in the last quarter. Finally, Gladwyn Financial Advisors Inc. purchased a new position in GE HealthCare Technologies during the second quarter valued at $34,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of recent research reports. Jefferies Financial Group increased their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Evercore increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday. Stifel Nicolaus raised their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday. Piper Sandler lifted their target price on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a report on Friday, January 9th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $80.65 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a 50-day moving average of $82.73 and a 200 day moving average of $77.54. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.95 and a current ratio of 1.37. The company has a market capitalization of $36.76 billion, a price-to-earnings ratio of 17.69, a PEG ratio of 2.43 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the prior year, the business earned $1.45 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.